Table of Content



1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Orphan Drugs
1.2 Key Market Segments
1.2.1 Orphan Drugs Segment by Type
1.2.2 Orphan Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats

2 Orphan Drugs Market Overview
2.1 Global Market Overview
2.1.1 Global Orphan Drugs Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Orphan Drugs Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 Orphan Drugs Market Competitive Landscape
3.1 Global Orphan Drugs Sales by Manufacturers (2017-2022)
3.2 Global Orphan Drugs Revenue Market Share by Manufacturers (2017-2022)
3.3 Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Orphan Drugs Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Orphan Drugs Sales Sites, Area Served, Product Type
3.6 Orphan Drugs Market Competitive Situation and Trends
3.6.1 Orphan Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Orphan Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion

4 Orphan Drugs Industry Chain Analysis
4.1 Orphan Drugs Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 The Development and Dynamics of Orphan Drugs Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 Orphan Drugs Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Orphan Drugs Sales Market Share by Type (2017-2022)
6.3 Global Orphan Drugs Market Size Market Share by Type (2017-2022)
6.4 Global Orphan Drugs Price by Type (2017-2022)

7 Orphan Drugs Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Orphan Drugs Market Sales by Application (2017-2022)
7.3 Global Orphan Drugs Market Size (M USD) by Application (2017-2022)
7.4 Global Orphan Drugs Sales Growth Rate by Application (2017-2022)

8 Orphan Drugs Market Segmentation by Region
8.1 Global Orphan Drugs Sales by Region
8.1.1 Global Orphan Drugs Sales by Region
8.1.2 Global Orphan Drugs Sales Market Share by Region
8.2 North America
8.2.1 North America Orphan Drugs Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Orphan Drugs Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Orphan Drugs Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Orphan Drugs Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Orphan Drugs Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa

9 Key Companies Profiled
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Orphan Drugs Basic Information
9.1.2 Bristol-Myers Squibb Orphan Drugs Product Overview
9.1.3 Bristol-Myers Squibb Orphan Drugs Product Market Performance
9.1.4 Bristol-Myers Squibb Business Overview
9.1.5 Bristol-Myers Squibb Orphan Drugs SWOT Analysis
9.1.6 Bristol-Myers Squibb Recent Developments
9.2 Roche
9.2.1 Roche Orphan Drugs Basic Information
9.2.2 Roche Orphan Drugs Product Overview
9.2.3 Roche Orphan Drugs Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Orphan Drugs SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Novartis
9.3.1 Novartis Orphan Drugs Basic Information
9.3.2 Novartis Orphan Drugs Product Overview
9.3.3 Novartis Orphan Drugs Product Market Performance
9.3.4 Novartis Business Overview
9.3.5 Novartis Orphan Drugs SWOT Analysis
9.3.6 Novartis Recent Developments
9.4 Johnson & Johnson
9.4.1 Johnson & Johnson Orphan Drugs Basic Information
9.4.2 Johnson & Johnson Orphan Drugs Product Overview
9.4.3 Johnson & Johnson Orphan Drugs Product Market Performance
9.4.4 Johnson & Johnson Business Overview
9.4.5 Johnson & Johnson Orphan Drugs SWOT Analysis
9.4.6 Johnson & Johnson Recent Developments
9.5 Pfizer
9.5.1 Pfizer Orphan Drugs Basic Information
9.5.2 Pfizer Orphan Drugs Product Overview
9.5.3 Pfizer Orphan Drugs Product Market Performance
9.5.4 Pfizer Business Overview
9.5.5 Pfizer Orphan Drugs SWOT Analysis
9.5.6 Pfizer Recent Developments
9.6 Amgen
9.6.1 Amgen Orphan Drugs Basic Information
9.6.2 Amgen Orphan Drugs Product Overview
9.6.3 Amgen Orphan Drugs Product Market Performance
9.6.4 Amgen Business Overview
9.6.5 Amgen Recent Developments
9.7 Sanofi
9.7.1 Sanofi Orphan Drugs Basic Information
9.7.2 Sanofi Orphan Drugs Product Overview
9.7.3 Sanofi Orphan Drugs Product Market Performance
9.7.4 Sanofi Business Overview
9.7.5 Sanofi Recent Developments
9.8 AstraZeneca
9.8.1 AstraZeneca Orphan Drugs Basic Information
9.8.2 AstraZeneca Orphan Drugs Product Overview
9.8.3 AstraZeneca Orphan Drugs Product Market Performance
9.8.4 AstraZeneca Business Overview
9.8.5 AstraZeneca Recent Developments
9.9 Takeda
9.9.1 Takeda Orphan Drugs Basic Information
9.9.2 Takeda Orphan Drugs Product Overview
9.9.3 Takeda Orphan Drugs Product Market Performance
9.9.4 Takeda Business Overview
9.9.5 Takeda Recent Developments
9.10 Vertex Pharmaceuticals
9.10.1 Vertex Pharmaceuticals Orphan Drugs Basic Information
9.10.2 Vertex Pharmaceuticals Orphan Drugs Product Overview
9.10.3 Vertex Pharmaceuticals Orphan Drugs Product Market Performance
9.10.4 Vertex Pharmaceuticals Business Overview
9.10.5 Vertex Pharmaceuticals Recent Developments
9.11 AbbVie
9.11.1 AbbVie Orphan Drugs Basic Information
9.11.2 AbbVie Orphan Drugs Product Overview
9.11.3 AbbVie Orphan Drugs Product Market Performance
9.11.4 AbbVie Business Overview
9.11.5 AbbVie Recent Developments
9.12 Biogen
9.12.1 Biogen Orphan Drugs Basic Information
9.12.2 Biogen Orphan Drugs Product Overview
9.12.3 Biogen Orphan Drugs Product Market Performance
9.12.4 Biogen Business Overview
9.12.5 Biogen Recent Developments
9.13 Eli Lilly
9.13.1 Eli Lilly Orphan Drugs Basic Information
9.13.2 Eli Lilly Orphan Drugs Product Overview
9.13.3 Eli Lilly Orphan Drugs Product Market Performance
9.13.4 Eli Lilly Business Overview
9.13.5 Eli Lilly Recent Developments
10 Orphan Drugs Market Forecast by Region
10.1 Global Orphan Drugs Market Size Forecast
10.2 Global Orphan Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Orphan Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Orphan Drugs Market Size Forecast by Region
10.2.4 South America Orphan Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Orphan Drugs by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Orphan Drugs Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Orphan Drugs by Type (2022-2028)
11.1.2 Global Orphan Drugs Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Orphan Drugs by Type (2022-2028)
11.2 Global Orphan Drugs Market Forecast by Application (2022-2028)
11.2.1 Global Orphan Drugs Sales (K Units) Forecast by Application
11.2.2 Global Orphan Drugs Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings



List of Figures

?LIST OF TABLES

Table 1. Introduction of the Type

Table 2. Introduction of the Application

Table 3. Market Size (M USD) Segment Executive Summary

Table 4. Orphan Drugs Market Size (M USD) Comparison by Region (M USD)

Table 5. Global Orphan Drugs Sales (K Units) by Manufacturers (2017-2022)

Table 6. Global Orphan Drugs Sales Market Share by Manufacturers (2017-2022)

Table 7. Global Orphan Drugs Revenue (M USD) by Manufacturers (2017-2022)

Table 8. Global Orphan Drugs Revenue Share by Manufacturers (2017-2022)

Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orphan Drugs as of 2021)

Table 10. Global Market Orphan Drugs Average Price (USD/Unit) of Key Manufacturers (2017-2022)

Table 11. Manufacturers Orphan Drugs Sales Sites and Area Served

Table 12. Manufacturers Orphan Drugs Product Type

Table 13. Global Orphan Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Mergers & Acquisitions, Expansion Plans

Table 15. Industry Chain Map of Orphan Drugs

Table 16. Raw Materials

Table 17. Midstream Market Analysis

Table 18. Downstream Customer Analysis

Table 19. Key Development Trends

Table 20. Driving Factors

Table 21. Orphan Drugs Market Challenges

Table 22. Market Restraints

Table 23. Global Orphan Drugs Sales by Type (K Units)

Table 24. Global Orphan Drugs Market Size by Type (M USD)

Table 25. Global Orphan Drugs Sales (K Units) by Type (2017-2022)

Table 26. Global Orphan Drugs Sales Market Share by Type (2017-2022)

Table 27. Global Orphan Drugs Market Size (M USD) by Type (2017-2022)

Table 28. Global Orphan Drugs Market Size Share by Type (2017-2022)

Table 29. Global Orphan Drugs Price (USD/Unit) by Type (2017-2022)

Table 30. Global Orphan Drugs Sales (K Units) by Application

Table 31. Global Orphan Drugs Market Size by Application

Table 32. Global Orphan Drugs Sales by Application (2017-2022) & (K Units)

Table 33. Global Orphan Drugs Sales Market Share by Application (2017-2022)

Table 34. Global Orphan Drugs Sales by Application (2017-2022) & (M USD)

Table 35. Global Orphan Drugs Market Share by Application (2017-2022)

Table 36. Global Orphan Drugs Sales Growth Rate by Application (2017-2022)

Table 37. Global Orphan Drugs Sales by Region (2017-2022) & (K Units)

Table 38. Global Orphan Drugs Sales Market Share by Region (2017-2022)

Table 39. North America Orphan Drugs Sales by Country (2017-2022) & (K Units)

Table 40. Europe Orphan Drugs Sales by Country (2017-2022) & (K Units)

Table 41. Asia Pacific Orphan Drugs Sales by Region (2017-2022) & (K Units)

Table 42. South America Orphan Drugs Sales by Country (2017-2022) & (K Units)

Table 43. Middle East and Africa Orphan Drugs Sales by Region (2017-2022) & (K Units)

Table 44. Bristol-Myers Squibb Orphan Drugs Basic Information

Table 45. Bristol-Myers Squibb Orphan Drugs Product Overview

Table 46. Bristol-Myers Squibb Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 47. Bristol-Myers Squibb Business Overview

Table 48. Bristol-Myers Squibb Orphan Drugs SWOT Analysis

Table 49. Bristol-Myers Squibb Recent Developments

Table 50. Roche Orphan Drugs Basic Information

Table 51. Roche Orphan Drugs Product Overview

Table 52. Roche Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 53. Roche Business Overview

Table 54. Roche Orphan Drugs SWOT Analysis

Table 55. Roche Recent Developments

Table 56. Novartis Orphan Drugs Basic Information

Table 57. Novartis Orphan Drugs Product Overview

Table 58. Novartis Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 59. Novartis Business Overview

Table 60. Novartis Orphan Drugs SWOT Analysis

Table 61. Novartis Recent Developments

Table 62. Johnson & Johnson Orphan Drugs Basic Information

Table 63. Johnson & Johnson Orphan Drugs Product Overview

Table 64. Johnson & Johnson Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 65. Johnson & Johnson Business Overview

Table 66. Johnson & Johnson Orphan Drugs SWOT Analysis

Table 67. Johnson & Johnson Recent Developments

Table 68. Pfizer Orphan Drugs Basic Information

Table 69. Pfizer Orphan Drugs Product Overview

Table 70. Pfizer Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 71. Pfizer Business Overview

Table 72. Pfizer Orphan Drugs SWOT Analysis

Table 73. Pfizer Recent Developments

Table 74. Amgen Orphan Drugs Basic Information

Table 75. Amgen Orphan Drugs Product Overview

Table 76. Amgen Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 77. Amgen Business Overview

Table 78. Amgen Recent Developments

Table 79. Sanofi Orphan Drugs Basic Information

Table 80. Sanofi Orphan Drugs Product Overview

Table 81. Sanofi Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 82. Sanofi Business Overview

Table 83. Sanofi Recent Developments

Table 84. AstraZeneca Orphan Drugs Basic Information

Table 85. AstraZeneca Orphan Drugs Product Overview

Table 86. AstraZeneca Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 87. AstraZeneca Business Overview

Table 88. AstraZeneca Recent Developments

Table 89. Takeda Orphan Drugs Basic Information

Table 90. Takeda Orphan Drugs Product Overview

Table 91. Takeda Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 92. Takeda Business Overview

Table 93. Takeda Recent Developments

Table 94. Vertex Pharmaceuticals Orphan Drugs Basic Information

Table 95. Vertex Pharmaceuticals Orphan Drugs Product Overview

Table 96. Vertex Pharmaceuticals Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 97. Vertex Pharmaceuticals Business Overview

Table 98. Vertex Pharmaceuticals Recent Developments

Table 99. AbbVie Orphan Drugs Basic Information

Table 100. AbbVie Orphan Drugs Product Overview

Table 101. AbbVie Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 102. AbbVie Business Overview

Table 103. AbbVie Recent Developments

Table 104. Biogen Orphan Drugs Basic Information

Table 105. Biogen Orphan Drugs Product Overview

Table 106. Biogen Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 107. Biogen Business Overview

Table 108. Biogen Recent Developments

Table 109. Eli Lilly Orphan Drugs Basic Information

Table 110. Eli Lilly Orphan Drugs Product Overview

Table 111. Eli Lilly Orphan Drugs Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)

Table 112. Eli Lilly Business Overview

Table 113. Eli Lilly Recent Developments

Table 114. Global Orphan Drugs Sales Forecast by Region (K Units)

Table 115. Global Orphan Drugs Market Size Forecast by Region (M USD)

Table 116. North America Orphan Drugs Sales Forecast by Country (2022-2028) & (K Units)

Table 117. North America Orphan Drugs Market Size Forecast by Country (2022-2028) & (M USD)

Table 118. Europe Orphan Drugs Sales Forecast by Country (2022-2028) & (K Units)

Table 119. Europe Orphan Drugs Market Size Forecast by Country (2022-2028) & (M USD)

Table 120. Asia Pacific Orphan Drugs Sales Forecast by Region (2022-2028) & (K Units)

Table 121. Asia Pacific Orphan Drugs Market Size Forecast by Region (2022-2028) & (M USD)

Table 122. South America Orphan Drugs Sales Forecast by Country (2022-2028) & (K Units)

Table 123. South America Orphan Drugs Market Size Forecast by Country (2022-2028) & (M USD)

Table 124. Middle East and Africa Orphan Drugs Consumption Forecast by Country (2022-2028) & (Units)

Table 125. Middle East and Africa Orphan Drugs Market Size Forecast by Country (2022-2028) & (M USD)

Table 126. Global Orphan Drugs Sales Forecast by Type (2022-2028) & (K Units)

Table 127. Global Orphan Drugs Market Size Forecast by Type (2022-2028) & (M USD)

Table 128. Global Orphan Drugs Price Forecast by Type (2022-2028) & (USD/Unit)

Table 129. Global Orphan Drugs Sales (K Units) Forecast by Application (2022-2028)

Table 130. Global Orphan Drugs Market Size Forecast by Application (2022-2028) & (M USD)

List of Figures

Figure 1. Product Picture of Orphan Drugs

Figure 2. Data Triangulation

Figure 3. Key Caveats

Figure 4. Global Orphan Drugs Market Size (M USD), 2017-2028

Figure 5. Global Orphan Drugs Market Size (M USD) (2017-2028)

Figure 6. Global Orphan Drugs Sales (K Units) & (2017-2028)

Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 9. Evaluation Matrix of Regional Market Development Potential

Figure 10. Orphan Drugs Market Size (M USD) by Country (M USD)

Figure 11. Orphan Drugs Sales Share by Manufacturers in 2020

Figure 12. Global Orphan Drugs Revenue Share by Manufacturers in 2020

Figure 13. Orphan Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 14. Global Market Orphan Drugs Average Price (USD/Unit) of Key Manufacturers in 2020

Figure 15. The Global 5 and 10 Largest Players: Market Share by Orphan Drugs Revenue in 2021

Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)

Figure 17. Global Orphan Drugs Market Share by Type

Figure 18. Sales Market Share of Orphan Drugs by Type (2017-2022)

Figure 19. Sales Market Share of Orphan Drugs by Type in 2021

Figure 20. Market Size Share of Orphan Drugs by Type (2017-2022)

Figure 21. Market Size Market Share of Orphan Drugs by Type in 2020

Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)

Figure 23. Global Orphan Drugs Market Share by Application

Figure 24. Global Orphan Drugs Sales Market Share by Application (2017-2022)

Figure 25. Global Orphan Drugs Sales Market Share by Application in 2021

Figure 26. Global Orphan Drugs Market Share by Application (2017-2022)

Figure 27. Global Orphan Drugs Market Share by Application in 2020

Figure 28. Global Orphan Drugs Sales Growth Rate by Application (2017-2022)

Figure 29. Global Orphan Drugs Sales Market Share by Region (2017-2022)

Figure 30. North America Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 31. North America Orphan Drugs Sales Market Share by Country in 2020

Figure 32. U.S. Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 33. Canada Orphan Drugs Sales (K Units) and Growth Rate (2017-2022)

Figure 34. Mexico Orphan Drugs Sales (Units) and Growth Rate (2017-2022)

Figure 35. Europe Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 36. Europe Orphan Drugs Sales Market Share by Country in 2020

Figure 37. Germany Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 38. France Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 39. U.K. Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 40. Italy Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 41. Russia Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 42. Asia Pacific Orphan Drugs Sales and Growth Rate (K Units)

Figure 43. Asia Pacific Orphan Drugs Sales Market Share by Region in 2020

Figure 44. China Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 45. Japan Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 46. South Korea Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 47. India Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 48. Southeast Asia Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 49. South America Orphan Drugs Sales and Growth Rate (K Units)

Figure 50. South America Orphan Drugs Sales Market Share by Country in 2020

Figure 51. Brazil Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 52. Argentina Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 53. Columbia Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 54. Middle East and Africa Orphan Drugs Sales and Growth Rate (K Units)

Figure 55. Middle East and Africa Orphan Drugs Sales Market Share by Region in 2020

Figure 56. Saudi Arabia Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 57. UAE Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 58. Egypt Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 59. Nigeria Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 60. South Africa Orphan Drugs Sales and Growth Rate (2017-2022) & (K Units)

Figure 61. Global Orphan Drugs Sales Forecast by Volume (2017-2028) & (K Units)

Figure 62. Global Orphan Drugs Market Size Forecast by Value (2017-2028) & (M USD)

Figure 63. Global Orphan Drugs Sales Market Share Forecast by Type (2022-2028)

Figure 64. Global Orphan Drugs Market Share Forecast by Type (2022-2028)

Figure 65. Global Orphan Drugs Sales Forecast by Application (2022-2028)

Figure 66. Global Orphan Drugs Market Share Forecast by Application (2022-2028)